Advanced search
1 file | 3.23 MB

Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system

Author
Organization
Abstract
Introduction: Management of atrial tachyarrhythmias represents a significant challenge in patients with implantable cardioverter defibrillators (ICDs). Drug therapy of these arrhythmias is limited by moderate efficacy, ventricular proarrhythmia, and drug-device interactions. This study tested the safety and efficacy of a new dual-chamber ICD to detect and treat atrial as well as ventricular tachyarrhythmias, Methods and Results: A dual-chamber ICD (Medtronic 7250 Jewel AF) was implanted in 293 of 303 patients at 49 centers in Europe, Canada, and North America. Specific data were collected at implant and during a mean follow-up period of 7.9 +/- 4.7 months. There were no clinically evident failures to detect and treat ventricular arrhythmias. In patients with at least one of the dual-chamber detection criteria activated, 1,056 of 1,192 episodes of ventricular tachycardia or fibrillation detected were judged to be appropriate (89 % positive predictive accuracy). Therapy efficacy was 100 % in the ventricular fibrillation zone and 98 % in the ventricular tachycardia zone. Positive predictive accuracy for detection of atrial episodes was 95 % (1,052/1,107), For episodes classified as atrial tachycardia by the device, the efficacy of atrial antitachycardia pacing and high-frequency (50-Hz) burst pacing was 55% and 17%, respectively. High-frequency burst pacing terminated 16.8% of episodes classified as atrial fibrillation, and atrial defibrillation had an estimated efficacy of 76 %. The actuarial estimates of 6-month complication-free survival and total survival were 88 % and 94 %, respectively. Conclusion: This novel dual-chamber ICD is capable of safely and effectively discriminating atrial from ventricular tachyarrhythmias and of treating atrial tachyarrhythmias without compromising detection and treatment of ventricular tachyarrhythmias.
Keywords
implantable cardioverter defibrillator, ventricular tachyarrhythmias, atrial fibrillation, ATRIAL-FIBRILLATION, MULTICENTER, PREVENTION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 3.23 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Schoels, Wolfgang, Charles D Swerdlow, Werner Jung, Kenneth M Stein, Karl Heinz Seidl, Charles Hafajee, the Worldwide Jewel AF investigators, and Luc Jordaens. 2001. “Worldwide Clinical Experience with a New Dual-chamber Implantable Cardioverter Defibrillator System.” Journal of Cardiovascular Electrophysiology 12 (5): 521–528.
APA
Schoels, W., Swerdlow, C. D., Jung, W., Stein, K. M., Seidl, K. H., Hafajee, C., Worldwide Jewel AF investigators, the, et al. (2001). Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 12(5), 521–528.
Vancouver
1.
Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl KH, Hafajee C, et al. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2001;12(5):521–8.
MLA
Schoels, Wolfgang et al. “Worldwide Clinical Experience with a New Dual-chamber Implantable Cardioverter Defibrillator System.” JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY 12.5 (2001): 521–528. Print.
@article{8048841,
  abstract     = {Introduction: Management of atrial tachyarrhythmias represents a significant challenge in patients with implantable cardioverter defibrillators (ICDs). Drug therapy of these arrhythmias is limited by moderate efficacy, ventricular proarrhythmia, and drug-device interactions. This study tested the safety and efficacy of a new dual-chamber ICD to detect and treat atrial as well as ventricular tachyarrhythmias, 
Methods and Results: A dual-chamber ICD (Medtronic 7250 Jewel AF) was implanted in 293 of 303 patients at 49 centers in Europe, Canada, and North America. Specific data were collected at implant and during a mean follow-up period of 7.9 +/- 4.7 months. There were no clinically evident failures to detect and treat ventricular arrhythmias. In patients with at least one of the dual-chamber detection criteria activated, 1,056 of 1,192 episodes of ventricular tachycardia or fibrillation detected were judged to be appropriate (89 % positive predictive accuracy). Therapy efficacy was 100 % in the ventricular fibrillation zone and 98 % in the ventricular tachycardia zone. Positive predictive accuracy for detection of atrial episodes was 95 % (1,052/1,107), For episodes classified as atrial tachycardia by the device, the efficacy of atrial antitachycardia pacing and high-frequency (50-Hz) burst pacing was 55% and 17%, respectively. High-frequency burst pacing terminated 16.8% of episodes classified as atrial fibrillation, and atrial defibrillation had an estimated efficacy of 76 %. The actuarial estimates of 6-month complication-free survival and total survival were 88 % and 94 %, respectively. 
Conclusion: This novel dual-chamber ICD is capable of safely and effectively discriminating atrial from ventricular tachyarrhythmias and of treating atrial tachyarrhythmias without compromising detection and treatment of ventricular tachyarrhythmias.},
  author       = {Schoels, Wolfgang and Swerdlow, Charles D and Jung, Werner and Stein, Kenneth M and Seidl, Karl Heinz and Hafajee, Charles and Worldwide Jewel AF investigators, the and Jordaens, Luc},
  issn         = {1045-3873},
  journal      = {JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY},
  keywords     = {implantable cardioverter defibrillator,ventricular tachyarrhythmias,atrial fibrillation,ATRIAL-FIBRILLATION,MULTICENTER,PREVENTION},
  language     = {eng},
  number       = {5},
  pages        = {521--528},
  title        = {Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system},
  url          = {http://dx.doi.org/10.1046/j.1540-8167.2001.00521.x},
  volume       = {12},
  year         = {2001},
}

Altmetric
View in Altmetric
Web of Science
Times cited: